Drugs / Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed
Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00006066 | ? → Jun 2006 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT00013871 | ? → Nov 2004 | HIV infectious disease, hepatitis B virus infection, measles, pertussis +1 | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00006066 ↗ |
| Modality | Vaccine | “Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed” NCT00006066 ↗ |